These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23000342)

  • 1. Nemo-like kinase, a multifaceted cell signaling regulator.
    Ishitani T; Ishitani S
    Cell Signal; 2013 Jan; 25(1):190-7. PubMed ID: 23000342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nemo-like kinase (NLK) acts downstream of Notch/Delta signalling to downregulate TCF during mesoderm induction in the sea urchin embryo.
    Röttinger E; Croce J; Lhomond G; Besnardeau L; Gache C; Lepage T
    Development; 2006 Nov; 133(21):4341-53. PubMed ID: 17038519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. nemo-like kinase is an essential co-activator of Wnt signaling during early zebrafish development.
    Thorpe CJ; Moon RT
    Development; 2004 Jun; 131(12):2899-909. PubMed ID: 15151990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.
    Kanei-Ishii C; Ninomiya-Tsuji J; Tanikawa J; Nomura T; Ishitani T; Kishida S; Kokura K; Kurahashi T; Ichikawa-Iwata E; Kim Y; Matsumoto K; Ishii S
    Genes Dev; 2004 Apr; 18(7):816-29. PubMed ID: 15082531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling.
    Masoumi KC; Daams R; Sime W; Siino V; Ke H; Levander F; Massoumi R
    Mol Biol Cell; 2017 Jan; 28(2):346-355. PubMed ID: 27903773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development.
    Satoh K; Ohnishi J; Sato A; Takeyama M; Iemura S; Natsume T; Shibuya H
    Mol Cell Biol; 2007 Nov; 27(21):7623-30. PubMed ID: 17785444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Jung KH; Kim JK; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Park WS; Lee JY; Nam SW
    J Cell Biochem; 2010 Jun; 110(3):687-96. PubMed ID: 20512928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of Nemo-like Kinase in T Cells Reduces Single-Positive CD8
    Daams R; Sime W; Leandersson K; Sitnicka E; Massoumi R
    J Immunol; 2020 Oct; 205(7):1830-1841. PubMed ID: 32839237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological significance of nemo-like kinase expression in glioma.
    Cui G; Li Z; Shao B; Zhao L; Zhou Y; Lu T; Wang J; Shi X; Wang J; Zuo G; Zhu W; Shen A
    J Clin Neurosci; 2011 Feb; 18(2):271-5. PubMed ID: 21177110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wip1 directly dephosphorylates NLK and increases Wnt activity during germ cell development.
    Cho SJ; Cha BS; Kwon OS; Lim J; Shin DM; Han DW; Ishitani T; Jho EH; Fornace AJ; Cha HJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):1013-1022. PubMed ID: 28185954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLK positively regulates Wnt/β-catenin signalling by phosphorylating LEF1 in neural progenitor cells.
    Ota S; Ishitani S; Shimizu N; Matsumoto K; Itoh M; Ishitani T
    EMBO J; 2012 Apr; 31(8):1904-15. PubMed ID: 22373574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT signaling pathway and stem cell signaling network.
    Katoh M; Katoh M
    Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling.
    Li M; Wang H; Huang T; Wang J; Ding Y; Li Z; Zhang J; Li L
    J Biol Chem; 2010 Apr; 285(18):13397-404. PubMed ID: 20194509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation.
    Nifuji A; Ideno H; Ohyama Y; Takanabe R; Araki R; Abe M; Noda M; Shibuya H
    Exp Cell Res; 2010 Apr; 316(7):1127-36. PubMed ID: 20116374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.
    Yasuda J; Tsuchiya A; Yamada T; Sakamoto M; Sekiya T; Hirohashi S
    Biochem Biophys Res Commun; 2003 Aug; 308(2):227-33. PubMed ID: 12901858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Nemo-like kinase after spinal cord injury in rats.
    Xu D; Zhao W; Pan G; Qian M; Zhu X; Liu W; Cai G; Cui Z
    J Mol Neurosci; 2014 Mar; 52(3):410-8. PubMed ID: 24395089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of retinal-neurite extension by beta-catenin signaling pathway.
    Ouchi Y; Tabata Y; Arai K; Watanabe S
    J Cell Sci; 2005 Oct; 118(Pt 19):4473-83. PubMed ID: 16179606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases.
    Sugimura R; Li L
    Birth Defects Res C Embryo Today; 2010 Dec; 90(4):243-56. PubMed ID: 21181886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.
    Kurahashi T; Nomura T; Kanei-Ishii C; Shinkai Y; Ishii S
    Mol Biol Cell; 2005 Oct; 16(10):4705-13. PubMed ID: 16055500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.